Tin tức & Cập nhật

Ixa-dex, pom-dex both effective in heavily pretreated relapsed, refractory multiple myeloma
Ixa-dex, pom-dex both effective in heavily pretreated relapsed, refractory multiple myeloma
08 Jun 2022
Microwave ablation: a better treatment alternative for NSCLC?
Microwave ablation: a better treatment alternative for NSCLC?
08 Jun 2022 bởiAudrey Abella

In patients with non-small-cell lung cancer (NSCLC), image-guided thermal ablation (IGTA) via microwave ablation (MWA) appears to deliver better survival benefit compared with another IGTA subtype, radiofrequency ablation (RFA), or stereotactic body radiation therapy (SBRT), according to a systematic review and meta-analysis presented at ATS 2022.

Microwave ablation: a better treatment alternative for NSCLC?
08 Jun 2022
Hodgkin lymphoma incidence rising in Asia, HK tops global rise in males
Hodgkin lymphoma incidence rising in Asia, HK tops global rise in males
08 Jun 2022 bởiChristina Lau

The incidence of Hodgkin lymphoma has increased in the past decade, especially in Asian countries, females, and the younger population, a global study has shown.

Hodgkin lymphoma incidence rising in Asia, HK tops global rise in males
08 Jun 2022
Does IBS elevate long-term risk of cancer?
Does IBS elevate long-term risk of cancer?
07 Jun 2022 bởiStephen Padilla

People with irritable bowel syndrome (IBS) are not at increased overall risk of cancer relative to the general population, reveals a study. On the contrary, those with IBS appear to have a lower risk of incident colorectal cancer (CRC) and cancer-specific mortality.

Does IBS elevate long-term risk of cancer?
07 Jun 2022
H. pylori eradication suppresses long-term gastric cancer risk
H. pylori eradication suppresses long-term gastric cancer risk
07 Jun 2022
High-frequency mutations seen in conjunctival melanoma
High-frequency mutations seen in conjunctival melanoma
06 Jun 2022

Patients with conjunctival melanoma exhibit a high frequency of BRAF and NRAS mutations, as well as ATRX and NF1 mutations, reports a study.

High-frequency mutations seen in conjunctival melanoma
06 Jun 2022